Study: Movement disorder ALS and cognitive disorder FTLD show strong molecular overlaps

Single-cell gene expression patterns in the brain, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for potential treatment.

David Orenstein | The Picower Institute for Learning and Memory • mit
March 22, 2024 ~9 min

Deciphering the cellular mechanisms behind ALS

Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.

Michaela Jarvis | School of Engineering • mit
March 6, 2024 ~8 min


Neurodegenerative disease can progress in newly identified patterns

A machine-learning method finds patterns of health decline in ALS, informing future clinical trial designs and mechanism discovery. The technique also extends to Alzheimer’s and Parkinson’s.

Lauren Hinkel | MIT-IBM Watson AI Lab • mit
Sept. 27, 2022 ~10 min

3 Questions: Anna Jagielska on printing artificial axons

How 3D-printed models of neuronal axons could accelerate development of new therapies to treat neurodegenerative disorders.

Shirley Goh | Deshpande Center for Technological Innovation • mit
June 29, 2021 ~7 min

A wearable sensor to help ALS patients communicate

Researchers have designed a skin-like device that can measure small facial movements in patients who have lost the ability to speak.

Anne Trafton | MIT News Office • mit
Oct. 22, 2020 ~8 min

Biologists discover function of gene linked to familial ALS | MIT News

Study in worms reveals gene loss can lead to accumulation of waste products in cells.

Anne Trafton | MIT News Office • mit
May 4, 2018 ~6 min

Fighting ALS with mind, hand, and heart | MIT News

With support from the MIT Sandbox Innovation Fund Program, an MIT spinoff is creating assistive technology for people with ALS.

Meg Murphy | School of Engineering • mit
July 29, 2016 ~10 min

Mapping molecular neighborhoods | MIT News

Associate Professor Ernest Fraenkel uses biological network modeling to identify new targets for disease.

Alice McCarthy | MIT Industrial Liaison Program • mit
July 5, 2016 ~7 min


/

1